Lotus Labs Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 4.05 Cr
as on 16-11-2024
- Company Age 25 Year, 25 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 25.16 Cr
as on 16-11-2024
- Revenue 1.53%
(FY 2023)
- Profit 15.12%
(FY 2023)
- Ebitda -6.42%
(FY 2023)
- Net Worth 9.66%
(FY 2023)
- Total Assets 9.30%
(FY 2023)
About Lotus Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.05 Cr.
The company has closed loans amounting to ₹25.16 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Gregg Derosa, Sanjog Sharma, and Anil Anand serve as directors at the Company.
- CIN/LLPIN
U73100MH1999PTC272443
- Company No.
272443
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 1999
- Date of AGM
28 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Lotus Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gregg Derosa  | Director | 07-Jan-2021 | Current |
Sanjog Sharma  | Director | 22-Mar-2021 | Current |
| Anil Anand | Director | 08-Jun-2023 | Current |
Financial Performance of Lotus Labs.
Lotus Labs Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.53% increase. The company also saw a substantial improvement in profitability, with a 15.12% increase in profit. The company's net worth moved up by a moderate rise of 9.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lotus Labs?
In 2023, Lotus Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 17 Oct 2007 | ₹2.40 Cr | Satisfied |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 07 Aug 2007 | ₹2.40 Cr | Satisfied |
Dbs Bank Limited Creation Date: 15 Jul 2007 | ₹10.00 Cr | Satisfied |
How Many Employees Work at Lotus Labs?
Lotus Labs has a workforce of 213 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lotus Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lotus Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
